BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9086789)

  • 1. [Verotoxin induced hemolytic uremic syndrome: pathophysiology of neurological involvement].
    Takagi C; Naruse T
    Nihon Rinsho; 1997 Mar; 55(3):731-5. PubMed ID: 9086789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal pathology of VTEC related HUS].
    Shigematsu H
    Nihon Rinsho; 1997 Mar; 55(3):721-5. PubMed ID: 9086787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome.
    Arbus GS
    Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verotoxin receptor glycolipid in human renal tissue.
    Boyd B; Lingwood C
    Nephron; 1989; 51(2):207-10. PubMed ID: 2644572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
    Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
    Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary tubular impairment by verocytotoxin in hemolytic uremic syndrome].
    Uchida H; Fujimoto J; Takeda T
    Nihon Rinsho; 1997 Mar; 55(3):726-30. PubMed ID: 9086788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1.
    Zoja C; Corna D; Farina C; Sacchi G; Lingwood C; Doyle MP; Padhye VV; Abbate M; Remuzzi G
    J Lab Clin Med; 1992 Aug; 120(2):229-38. PubMed ID: 1323633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology.
    Lingwood CA
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):375-86. PubMed ID: 10571026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemorrhagic colitis and hemolytic-uremic syndrome--E. coli as the etiologic agent. I. Bacteriology and pathogenesis].
    Tschäpe H; Böhme G
    Kinderarztl Prax; 1991 Jun; 59(6):161-5. PubMed ID: 1921166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Escherichia coli verotoxin (relationship between verotoxin produced by E. coli O157: H7 and HUS)].
    Matsunaga T; Komoda T
    Nihon Rinsho; 1999 Nov; 57 Suppl():172-5. PubMed ID: 10635805
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemolytic uremic syndrome].
    Arai T; Matsuzaki K
    Nihon Rinsho; 1996 Sep; 54(9):2551-60. PubMed ID: 8890593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive indicators for progression to severe complications(hemolytic-uremic syndrome and encephalopathy) and their prevention in enterohemorrhagic Escherichia coli infection].
    Joh K
    Nihon Rinsho; 1997 Mar; 55(3):700-5. PubMed ID: 9086784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy for children with Shiga toxin-E. coli-associated hemolytic uremic syndrome].
    Ito K; Hattori M; Matsumoto N
    Nihon Rinsho; 2002 Jun; 60(6):1126-30. PubMed ID: 12078084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics and molecular biology of verotoxin produced by enterohemorrhagic Escherichia coli].
    Iijima Y; Honda T
    Nihon Rinsho; 1997 Mar; 55(3):646-50. PubMed ID: 9086774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera.
    Watarai S; Yokota K; Tana ; Kishimoto T; Kanadani T; Taketa K; Oguma K
    J Clin Microbiol; 2001 Feb; 39(2):798-800. PubMed ID: 11158156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli.
    Kamitsuji H; Nonami K; Murakami T; Ishikawa N; Nakayama A; Umeki Y
    Clin Nephrol; 2000 May; 53(5):319-24. PubMed ID: 11305804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
    Gunzer F; Hennig-Pauka I; Waldmann KH; Sandhoff R; Gröne HJ; Kreipe HH; Matussek A; Mengel M
    Am J Clin Pathol; 2002 Sep; 118(3):364-75. PubMed ID: 12219778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.